Atea Pharmaceuticals Appoints Janet Hammond, M.D., Ph.D., as Chief Development Officer
BOSTON, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections, today announced the appointment of Janet Hammond, …